Literature DB >> 22871871

Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010.

Brian K Kit1, Margaret D Carroll, David A Lacher, Paul D Sorlie, Janet M DeJesus, Cyntjl Ogden.   

Abstract

CONTEXT: For more than 20 years, primary prevention of coronary heart disease has included strategies intended to improve overall serum lipid concentrations among youths.
OBJECTIVE: To examine trends in lipid concentrations among youths from 1988-1994 through 2007-2010. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analysis of serum lipid concentrations among 16,116 youths aged 6 to 19 years who participated in the nationally representative National Health and Nutrition Examination Survey during 3 time periods: 1988-1994, 1999-2002, and 2007-2010. MAIN OUTCOME MEASURES: Among all youths, mean serum total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), high-density lipoprotein cholesterol (HDL-C); and among adolescents only, low-density lipoprotein cholesterol (LDL-C) and geometric mean triglyceride levels. Trends in adverse lipid concentrations are reported for TC levels of 200 mg/dL and greater, non-HDL-C levels of 145 mg/dL and greater, HDL-C levels of less than 40 mg/dL, LDL-C levels of 130 mg/dL and greater, and triglyceride levels of 130 mg/dL and greater.
RESULTS: Among youths aged 6 to 19 years between 1988-1994 and 2007-2010, there was a decrease in mean TC (from 165 mg/dL [95% CI, 164-167] to 160 mg/dL [95% CI, 158-161]; P < .001) and a decrease in the prevalence of elevated TC (from 11.3% [95% CI, 9.8%-12.7%] to 8.1% [95% CI, 6.7%-9.5%]; P = .002). Mean HDL-C significantly increased between 1988-1994 and 2007-2010, but the prevalence of low HDL-C did not change. Mean non-HDL-C and prevalence of elevated non-HDL-C both significantly decreased over the study period. In 2007-2010, 22% (95% CI, 20.3%-23.6%) of youths had either a low HDL-C level or high non-HDL-C, which was lower than the 27.2% (95% CI, 24.6%-29.7%) in 1988-1994 (P = .001). Among adolescents (aged 12-19 years) between 1988-1994 and 2007-2010, there was a decrease in mean LDL-C (from 95 mg/dL [95% CI, 92-98] to 90 mg/dL [95% CI, 88-91]; P = .003) and a decrease in geometric mean triglycerides (from 82 mg/dL [95% CI, 78-86] to 73 mg/dL [95% CI, 70-76]; P < .001). Prevalence of elevated LDL-C and triglycerides between 1988-1994 and 2007-2010 also significantly decreased.
CONCLUSIONS: Between 1988-1994 and 2007-2010, a favorable trend in serum lipid concentrations was observed among youths in the United States but almost 1 in 10 had elevated TC in 2007-2010.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871871     DOI: 10.1001/jama.2012.9136

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  44 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Physicians' Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening.

Authors:  Christopher W Valle; Helen J Binns; Maheen Quadri-Sheriff; Irwin Benuck; Angira Patel
Journal:  Clin Pediatr (Phila)       Date:  2015-03-26       Impact factor: 1.168

Review 3.  Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Authors:  Jonathan Wagner; Susan M Abdel-Rahman
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

4.  Adolescent Perceptions of Cholesterol Screening Results: "Young Invincibles" or Developing Adults?

Authors:  Holly C Gooding; R Christopher Sheldrick; Laurel K Leslie; Supriya Shah; Sarah D de Ferranti; Thomas I Mackie
Journal:  J Adolesc Health       Date:  2016-05-05       Impact factor: 5.012

5.  Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors.

Authors:  Sally Sultan; Michael Dowling; Adam Kirton; Gabrielle DeVeber; Alexandra Linds; Mitchell S V Elkind
Journal:  Pediatr Neurol       Date:  2017-10-10       Impact factor: 3.372

Review 6.  Pediatric lipid management: an earlier approach.

Authors:  Justin P Zachariah; Philip K Johnson
Journal:  Endocrinol Metab Clin North Am       Date:  2014-12       Impact factor: 4.741

7.  Added sugars in the diet are positively associated with diastolic blood pressure and triglycerides in children.

Authors:  Kenneth P Kell; Michelle I Cardel; Michelle M Bohan Brown; José R Fernández
Journal:  Am J Clin Nutr       Date:  2014-04-09       Impact factor: 7.045

8.  Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease.

Authors:  Kathryn E Harlow; Jonathan A Africa; Alan Wells; Patricia H Belt; Cynthia A Behling; Ajay K Jain; Jean P Molleston; Kimberly P Newton; Philip Rosenthal; Miriam B Vos; Stavra A Xanthakos; Joel E Lavine; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2018-04-13       Impact factor: 4.406

9.  NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease.

Authors:  Justin P Zachariah; Sarah D de Ferranti
Journal:  Future Cardiol       Date:  2013-01

10.  Blood lipids among young children in Europe: results from the European IDEFICS study.

Authors:  S De Henauw; N Michels; K Vyncke; A Hebestreit; P Russo; T Intemann; J Peplies; A Fraterman; G Eiben; M de Lorgeril; M Tornaritis; D Molnar; T Veidebaum; W Ahrens; L A Moreno
Journal:  Int J Obes (Lond)       Date:  2014-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.